Key result
Intravenous M-II terminated 2 of 2 atrial fibrillation and 8 of 10 atrial flutter episodes in a canine sterile pericarditis model.
Why the study?
Does intravenous M-II terminate induced atrial flutter or atrial fibrillation in a canine sterile pericarditis model?
Does intravenous M-II terminate induced atrial flutter or atrial fibrillation in a canine sterile pericarditis model?
M-II, the main metabolite of K201, effectively terminates atrial flutter and fibrillation in a canine sterile pericarditis model by causing block in the area of slow conduction.
Answers are grounded in this paper and cite their sources.
Should not change AF management; leaves open translation of M-II efficacy from canine models to patients.
INTRODUCTION: K201, a 1,4-benzodiazepine derivative, acts on multiple cardiac ion channels and the ryanodine receptor. We tested whether administration of M-II, the main metabolite of K201, would terminate induced atrial flutter (AFL) or atrial fibrillation (AF) in the canine sterile pericarditis model. METHODS: In 6 dogs, electrophysiologic studies were performed at baseline and after drug administration, measuring atrial effective refractory period (AERP), and conduction time from 3 sites during pacing at cycle lengths (400, 300, and 200 milliseconds) on postoperative days 1-4. In 12 induced episodes of sustained AF/AFL (2/10, respectively), M-II was administered intravenously to test efficacy. Five of the AFL episodes were studied in the open chest state during simultaneous multisite atrial mapping. RESULTS: M-II terminated 2/2 AF and 8/10 AFL episodes, prolonged AERP (P < 0.05), significantly increased atrial pacing capture thresholds but did not significantly change atrial conduction time. AFL CL prolongation was largely explained by prolonged conduction in an area of slow conduction in the reentrant circuit. AFL terminated with block in the area of slow conduction. CONCLUSIONS: M-II was very effective in terminating AFL/AF in the canine sterile pericarditis model. AFL terminated due to block in the area of slow conduction of the reentrant circuit.
No takes yet. Share an insight, caveat, or question.
Sadrpour et al. (2015) studied Induced atrial flutter or atrial fibrillation (n=6). M-II vs. baseline was evaluated on Termination of induced atrial flutter or atrial fibrillation. Intravenous M-II terminated 2 of 2 atrial fibrillation and 8 of 10 atrial flutter episodes in a canine sterile pericarditis model.
Synapse has enriched 10 related papers. Consider them for comparative context: